Hepatitis Monthly

Published by: Kowsar

Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection

Ashraf Mohamadkhani 1 , Faegh Bastani 1 , Samaneh Khorrami 1 , Reza Ghanbari 1 , Sareh Eghtesad 1 , Maryam Sharafkhah 1 , Ghodratollah Montazeri 1 and Hossein Poustchi 1 , *
Authors Information
1 Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: June 2015, 15 (6); e28315
  • Published Online: June 23, 2015
  • Article Type: Research Article
  • Received: February 28, 2015
  • Revised: April 25, 2015
  • Accepted: April 28, 2015
  • DOI: 10.5812/hepatmon.28315v2

To Cite: Mohamadkhani A, Bastani F, Khorrami S, Ghanbari R, Eghtesad S, et al. Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection, Hepat Mon. 2015 ;15(6):e28315. doi: 10.5812/hepatmon.28315v2.

Abstract
Copyright: Copyright © 2015, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008; 48(2): 335-52[DOI][PubMed]
  • 2. Shoaei SD, Sali S, Karamipour M, Riahi E. Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. Hepat Mon. 2014; 14(2)[DOI][PubMed]
  • 3. Brunetto MR, Oliveri F, Colombatto P, Moriconi F, Ciccorossi P, Coco B, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology. 2010; 139(2): 483-90[DOI][PubMed]
  • 4. Mohamadkhani A, Katoonizadeh A, Poustchi H. Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP. Middle East J Dig Dis. 2015; 7(1): 5-13[PubMed]
  • 5. Zare-Bidaki M, Tsukiyama-Kohara K, Arababadi MK. Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis. Viral Immunol. 2014; 27(7): 321-6[DOI][PubMed]
  • 6. Moradzadeh M, Tayebi S, Poustchi H, Sayehmiri K, Shahnazari P, Naderi E, et al. The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation. Adv Virol. 2013; 2013: 780319[DOI][PubMed]
  • 7. Bocher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouval D, et al. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology. 2000; 31(2): 480-7[DOI][PubMed]
  • 8. Li YC, Chen Y, Liu W, Thadhani R. MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J Steroid Biochem Mol Biol. 2014; 144 Pt A: 81-6[DOI][PubMed]
  • 9. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009; 136(1): 26-36[DOI][PubMed]
  • 10. Li L, Guo Z, Wang J, Mao Y, Gao Q. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci. 2012; 57(11): 2910-6[DOI][PubMed]
  • 11. Zhang X, Hou J, Lu M. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Front Genet. 2013; 4: 202[DOI][PubMed]
  • 12. Mohamadkhani A. Long Noncoding RNAs in Interaction With RNA Binding Proteins in Hepatocellular Carcinoma. Hepat Mon. 2014; 14(5)[DOI][PubMed]
  • 13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2): 281-97[PubMed]
  • 14. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006; 25(17): 2537-45[DOI][PubMed]
  • 15. Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T. MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009; 125(6): 1328-33[DOI][PubMed]
  • 16. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002; 51(5): 1367-74[PubMed]
  • 17. Hewison M. Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl. 2012; 243: 92-102[DOI][PubMed]
  • 18. Carlberg C, Campbell MJ. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids. 2013; 78(2): 127-36[DOI][PubMed]
  • 19. Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, et al. Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol. 2009; 157(1): 48-59[PubMed]
  • 20. Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013; 58(4): 1270-6[PubMed]
  • 21. Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, et al. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 2014; 60(4): 1222-30[DOI][PubMed]
  • 22. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6): 696-9
  • 23. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology. 2004; 126(7): 1750-8[PubMed]
  • 24. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014; 42-73[DOI][PubMed]
  • 25. Hu J, Wang Z, Liao BY, Yu L, Gao X, Lu S, et al. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. Int J Cancer. 2014; 135(5): 1187-94[DOI][PubMed]
  • 26. Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012; 57(4): 897-909[DOI][PubMed]
  • 27. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, et al. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat. 2008; 15(10): 753-60[PubMed]
  • 28. Lee DY, Deng Z, Wang CH, Yang BB. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A. 2007; 104(51): 20350-5[DOI][PubMed]
  • 29. Maldonado RA, von Andrian UH. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010; 108: 111-65[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader